Identifying new biomarkers to predict cardiovascular events
Bio-collection for the Discovery of New Biomarkers for the Prediction of Cardiovascular Events
This study is trying to find new biological markers in patients that can help predict heart problems before they happen.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT04809506 on ClinicalTrials.gov |
What this trial studies
This project aims to collect biological samples from patients at the Centre for Screening and Prevention of Atherosclerosis at Toulouse University Hospital. The primary goal is to validate new biomarkers that can predict future cardiovascular events, addressing the limitations of existing risk factors. Patients will undergo a comprehensive evaluation, including interviews about lifestyle and clinical examinations, alongside blood sample collection for further analysis. The study also seeks to explore genetic polymorphisms that may influence susceptibility to atherosclerotic diseases.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 who are consulting for cardiovascular risk management, either in primary or secondary prevention.
Not a fit: Patients under 18 or those under legal protection will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved prediction and prevention strategies for cardiovascular diseases.
How similar studies have performed: Other studies have shown promise in identifying biomarkers for cardiovascular events, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults over 18 yrs; * consulting the Centre for Screening and Prevention of Atherosclerosis (CDPA) for management of their cardiovascular risk factors; * patients on primary prevention, free of personal history of coronary artery disease, stroke or lower limb arteriopathy, or patients on secondary prevention having presented one of the above mentioned diseases; * patients affiliated to a health insurance system; * patients having given their written informed consent for a participation to the study and for possible genetic analysis of their personal traits. Exclusion Criteria: * Patients under the age of 18; * patients being under legal protection
Where this trial is running
Toulouse
- University Hospital Toulouse — Toulouse, France (Recruiting)
Study contacts
- Principal investigator: Jean Ferrieres, MD PhD — University Hospital, Toulouse
- Study coordinator: Jean Ferrières, MD PhD
- Email: ferrieres.j@chu-toulouse.fr
- Phone: 562323728
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.